Literature DB >> 16050816

Pharmacokinetics of levofloxacin after single intravenous and repeat oral administration to cats.

G A Albarellos1, L A Ambros, M F Landoni.   

Abstract

The pharmacokinetic properties of the fluoroquinolone levofloxacin, were investigated in five cats after single intravenous and repeat oral administration at a daily dose of 10 mg/kg. Levofloxacin serum concentration was analyzed by microbiological assay using Klebsiella pneumoniae ATCC 10031 as test microorganism. Serum levofloxacin disposition after intravenous and oral dosing was best fitted to a bicompartmental and a monocompartmental open models with first-order elimination, respectively. After intravenous administration, distribution was rapid (t(1/2(d)) 0.26 +/- 0.18 h) and wide as reflected by the steady-state volume of distribution of 1.75 +/- 0.42 L/kg. Drug elimination was slow with a total body clearance of 0.14 +/- 0.04 L/h.kg and a t(1/2) for this process of 9.31 +/- 1.63 h. The mean residence time was of 12.99 +/- 2.12 h. After repeat oral administration, absorption half-life was of 0.18 +/- 0.12 h and Tmax of 1.62 +/- 0.84 h. The bioavailability was high (86.27 +/- 43.73%) with a peak plasma concentration at the steady state of 4.70 +/- 0.91 microg/mL. Drug accumulation was not significant after four oral administrations. Estimated efficacy predictors for levofloxacin after either intravenous or oral administration indicate a good profile against bacteria with a MIC value below of 0.5 microg/mL. However, for microorganisms with MIC values of 1 microg/mL it would be efficacious only when administered intravenously.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16050816     DOI: 10.1111/j.1365-2885.2005.00669.x

Source DB:  PubMed          Journal:  J Vet Pharmacol Ther        ISSN: 0140-7783            Impact factor:   1.786


  5 in total

1.  Prediction of the pharmacokinetics and tissue distribution of levofloxacin in humans based on an extrapolated PBPK model.

Authors:  Liqin Zhu; Yuan Zhang; Jianwei Yang; Yongming Wang; Jianlei Zhang; Yuanyuan Zhao; Weilin Dong
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2015-03-10       Impact factor: 2.441

2.  Disposition kinetics of levofloxacin in sheep after intravenous and intramuscular administration.

Authors:  Ayman Goudah; Sherifa Hasabelnaby
Journal:  Vet Med Int       Date:  2010-11-02

3.  Comparative pharmacokinetics of levofloxacin in healthy volunteers and in patients suffering from typhoid Fever.

Authors:  Muhammad Usman; Muhammad Ashraf; Muhammad Imran Khokhar; Bilal Ashiq; Muhammad Irfan Masood; Shehryar Afzal; Ovais Omer; Mohsin Ali; M Imran Qadir
Journal:  Iran J Pharm Res       Date:  2013       Impact factor: 1.696

4.  Comparative Pharmacokinetics of Levofloxacin in Healthy and Renal Damaged Muscovy Ducks following Intravenous and Oral Administration.

Authors:  Mohamed Aboubakr; Ahmed Soliman
Journal:  Vet Med Int       Date:  2014-02-04

5.  Pharmacokinetic profiles of levofloxacin after intravenous, intramuscular and subcutaneous administration to rabbits (Oryctolagus cuniculus).

Authors:  Andrejs Sitovs; Laura Voiko; Dmitrijs Kustovs; Liga Kovalcuka; Dace Bandere; Santa Purvina; Mario Giorgi
Journal:  J Vet Sci       Date:  2020-03       Impact factor: 1.672

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.